BeStock  
Stocks › Biotechnology › XENE

Xenon Pharmaceuticals XENE

US equityMarket cap rank #2284Biotechnology
$37.04 −$0.52 (-1.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $37.04 0.00%
Open$37.22
Prev close$37.56
Day range$36.81 – $37.97
Volume1.09M
Market cap$3.64B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership113.1%+6.33 pts vs. prior quarter
Institutions holding379-10 vs. prior quarter
Insider trades (recent)34 buys / 16 sellsNet buying
Short interest7.60% of floatDays to cover 6.4 · as of 30 Oct 2026
Short-sale volume share22.6%5-day average of daily volume

Short-sale volume as % of daily volume

9%17%26%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.49M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$7.2MSuper+$1.7MBig+$2.2MMid+$4.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.3% of shares outstanding.

Largest holders

  • FMR11.76%
  • T. Rowe Price Group, Inc.10.16%
  • BlackRock7.84%
  • Avoro Capital Advisors LLC5.88%
  • Polar Capital Holdings Plc4.65%
  • Driehaus Capital Management LLC4.50%
  • Janus Henderson Group plc4.26%
  • Capital Research2.94%

By investor type

  • Mutual Fund78.81%
  • Hedge Fund27.18%
  • VC/PE Fund2.62%
  • Public Company2.27%
  • Insurance Company0.90%
  • Government Pension Fund0.73%
  • Private Company0.33%
  • Family Office/Trust0.26%

Reported short interest has risen from 5.85% to 7.60% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +4,568,360 10.2%
FMR Mutual Fund 2026/Q3 +1,906,450 11.8%
Capricorn Fund Managers Limited Hedge Fund 2026/Q3 +547,900 0.6%
Barclays PLC Public Company 2026/Q3 +453,614 0.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +433,471 0.7%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +280,349 1.5%
Westfield Capital Management Company, L.P. Mutual Fund 2026/Q3 +271,664 1.8%
BlackRock Mutual Fund 2026/Q3 +187,931 7.8%
Morgan Stanley Public Company 2026/Q3 +157,994 0.6%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +157,994 0.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +361,502 0.6%
FMR Mutual Fund 2026/Q3 +211,810 10.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +3,135,254 5.6%
BlackRock Mutual Fund 2026/Q3 +1,882,364 7.8%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +1,036,763 1.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Oct 2026 Thomas Kelly Chief Financial Officer Derivative Exercise and Retained +7,500 – 22,500
29 Sep 2026 Thomas Kelly Chief Financial Officer Open Market Acquisition +15,000 $37.32 15,000
29 Sep 2026 Ian Mortimer Chief Executive Officer Open Market Acquisition +30,000 $37.38 64,223
31 Aug 2026 Dawn Svoronos Independent Chairperson Derivative Exercise and Retained +5,144 $8.15 31,373
27 Aug 2026 Christopher Kenney Chief Medical Officer Automatic Disposition -7,068 $60.98 2
10 Aug 2026 Steven Gannon Independent Director Open Market Disposition -10,000 $64.06 1,870
4 Jun 2026 Gary Patou Independent Director Automatic Disposition -1,322 $53.14 29,798
4 Jun 2026 Gillian Cannon Independent Director Automatic Disposition -1,190 $53.14 1,455
2 Jun 2026 Justin Gover Independent Director Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 Justin Gover Independent Director Other Derivative Acquisition +10,507 $53.46 10,507
2 Jun 2026 Gary Patou Independent Director Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 Gary Patou Independent Director Other Derivative Acquisition +10,507 $53.46 10,507
2 Jun 2026 C. Machado Independent Director Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 C. Machado Independent Director Other Derivative Acquisition +10,507 $53.46 10,507
2 Jun 2026 Steven Gannon Independent Director Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 Steven Gannon Independent Director Other Derivative Acquisition +10,507 $53.46 10,507
2 Jun 2026 Dawn Svoronos Independent Chairperson Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 Dawn Svoronos Independent Chairperson Other Derivative Acquisition +10,507 $53.46 10,507
2 Jun 2026 Gillian Cannon Independent Director Other Derivative Acquisition +1,593 – 1,593
2 Jun 2026 Gillian Cannon Independent Director Other Derivative Acquisition +10,507 $53.46 10,507

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,363,365 7.6% 6.4
15 Oct 2026 7,348,577 7.6% 4.0
30 Sep 2026 6,041,487 6.2% 1.6
15 Sep 2026 6,444,815 6.7% 12.2
31 Aug 2026 6,344,135 6.6% 9.1
14 Aug 2026 5,668,994 5.9% 9.2

Discussion

No comments yet — be the first to weigh in on XENE.

Sign in to join the discussion.

Scroll to Top